Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

10.22
Delayed Data
As of May 03
 -0.63 / -5.81%
Today’s Change
6.96
Today|||52-Week Range
25.25
-41.03%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close10.85
Today’s open10.67
Day’s range10.18 - 10.72
Volume1,246,133
Average volume (3 months)1,809,129
Market cap$1.4B
Dividend yield--
Data as of 05/03/2016

Growth & Valuation

Earnings growth (last year)+55.36%
Earnings growth (this year)-283.37%
Earnings growth (next 5 years)--
Revenue growth (last year)+79.28%
P/E ratioNM
Price/Sales16.26
Price/Book32.34

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd-0.64-4.53%
NVAXNovavax Inc-0.29-5.45%
FPRXFive Prime Therapeut...-3.21-6.62%
RDUSRadius Health Inc-1.38-3.77%
Data as of 05/03/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$135.1M
Annual profit (last year)-$32.2M
Net profit margin-23.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

Partner Offers

Search for Jobs